Cargando…
Reevaluation of missed lung cancer with artificial intelligence
Lung cancer is often missed on chest radiographs, despite chest radiography typically being the first imaging modality in the diagnosis pathway. We present a 46 year-old male with chest pain referred for chest X-ray, and initial interpretation reported no abnormality within the patient's lungs....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472074/ https://www.ncbi.nlm.nih.gov/pubmed/36118268 http://dx.doi.org/10.1016/j.rmcr.2022.101733 |
_version_ | 1784789227711496192 |
---|---|
author | Sicular, Serge Alpaslan, Mehmet Ortega, Francis A. Keathley, Nora Venkatesh, Srivas Jones, Rebecca M. Lindsey, Robert V. |
author_facet | Sicular, Serge Alpaslan, Mehmet Ortega, Francis A. Keathley, Nora Venkatesh, Srivas Jones, Rebecca M. Lindsey, Robert V. |
author_sort | Sicular, Serge |
collection | PubMed |
description | Lung cancer is often missed on chest radiographs, despite chest radiography typically being the first imaging modality in the diagnosis pathway. We present a 46 year-old male with chest pain referred for chest X-ray, and initial interpretation reported no abnormality within the patient's lungs. The patient was discharged but returned 4 months later with persistent and worsening symptoms. At this time, chest X-ray was again performed and revealed an enlarging left perihilar mass with post-obstructive atelectasis in the left lower lobe. Follow-up chest computerized tomography scan confirmed lung cancer with post-obstructive atelectasis, and subsequent bronchoscopy-assisted biopsy confirmed squamous cell carcinoma. Retrospective analysis of the initial chest radiograph, which had reported normal findings, was performed with Chest-CAD, a Food and Drug Administration (FDA) cleared computer-assisted detection (CAD) software device that analyzes chest radiograph studies using artificial intelligence. The device highlighted the perihilar region of the left lung as suspicious. Additional information provided by artificial intelligence software holds promise to prevent missed detection of lung cancer on chest radiographs. |
format | Online Article Text |
id | pubmed-9472074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94720742022-09-15 Reevaluation of missed lung cancer with artificial intelligence Sicular, Serge Alpaslan, Mehmet Ortega, Francis A. Keathley, Nora Venkatesh, Srivas Jones, Rebecca M. Lindsey, Robert V. Respir Med Case Rep Case Report Lung cancer is often missed on chest radiographs, despite chest radiography typically being the first imaging modality in the diagnosis pathway. We present a 46 year-old male with chest pain referred for chest X-ray, and initial interpretation reported no abnormality within the patient's lungs. The patient was discharged but returned 4 months later with persistent and worsening symptoms. At this time, chest X-ray was again performed and revealed an enlarging left perihilar mass with post-obstructive atelectasis in the left lower lobe. Follow-up chest computerized tomography scan confirmed lung cancer with post-obstructive atelectasis, and subsequent bronchoscopy-assisted biopsy confirmed squamous cell carcinoma. Retrospective analysis of the initial chest radiograph, which had reported normal findings, was performed with Chest-CAD, a Food and Drug Administration (FDA) cleared computer-assisted detection (CAD) software device that analyzes chest radiograph studies using artificial intelligence. The device highlighted the perihilar region of the left lung as suspicious. Additional information provided by artificial intelligence software holds promise to prevent missed detection of lung cancer on chest radiographs. Elsevier 2022-08-27 /pmc/articles/PMC9472074/ /pubmed/36118268 http://dx.doi.org/10.1016/j.rmcr.2022.101733 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Sicular, Serge Alpaslan, Mehmet Ortega, Francis A. Keathley, Nora Venkatesh, Srivas Jones, Rebecca M. Lindsey, Robert V. Reevaluation of missed lung cancer with artificial intelligence |
title | Reevaluation of missed lung cancer with artificial intelligence |
title_full | Reevaluation of missed lung cancer with artificial intelligence |
title_fullStr | Reevaluation of missed lung cancer with artificial intelligence |
title_full_unstemmed | Reevaluation of missed lung cancer with artificial intelligence |
title_short | Reevaluation of missed lung cancer with artificial intelligence |
title_sort | reevaluation of missed lung cancer with artificial intelligence |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472074/ https://www.ncbi.nlm.nih.gov/pubmed/36118268 http://dx.doi.org/10.1016/j.rmcr.2022.101733 |
work_keys_str_mv | AT sicularserge reevaluationofmissedlungcancerwithartificialintelligence AT alpaslanmehmet reevaluationofmissedlungcancerwithartificialintelligence AT ortegafrancisa reevaluationofmissedlungcancerwithartificialintelligence AT keathleynora reevaluationofmissedlungcancerwithartificialintelligence AT venkateshsrivas reevaluationofmissedlungcancerwithartificialintelligence AT jonesrebeccam reevaluationofmissedlungcancerwithartificialintelligence AT lindseyrobertv reevaluationofmissedlungcancerwithartificialintelligence |